Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GRI

GRI Bio, Inc.

CIK 0001824293 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.78
↑ 0.01 (0.56%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$3.15M
P/E Ratio
-0.29
EPS
-121.80
Dividend Yield
Not covered
52W Position
25%
Beta
1.06

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.30
P/S
Not covered
EV/Revenue
Not covered
ROE
-103.4%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 25%
$0.18$6.70

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$11.96M
Total Assets
$8.67M
Free Cash Flow
-$10.19M

Recent news